Cargando…

Measles vaccination in humanitarian emergencies: a review of recent practice

BACKGROUND: The health needs of children and adolescents in humanitarian emergencies are critical to the success of relief efforts and reduction in mortality. Measles has been one of the major causes of child deaths in humanitarian emergencies and further contributes to mortality by exacerbating mal...

Descripción completa

Detalles Bibliográficos
Autores principales: Grais, Rebecca F, Strebel, Peter, Mala, Peter, Watson, John, Nandy, Robin, Gayer, Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195113/
https://www.ncbi.nlm.nih.gov/pubmed/21942984
http://dx.doi.org/10.1186/1752-1505-5-21
_version_ 1782214069895299072
author Grais, Rebecca F
Strebel, Peter
Mala, Peter
Watson, John
Nandy, Robin
Gayer, Michelle
author_facet Grais, Rebecca F
Strebel, Peter
Mala, Peter
Watson, John
Nandy, Robin
Gayer, Michelle
author_sort Grais, Rebecca F
collection PubMed
description BACKGROUND: The health needs of children and adolescents in humanitarian emergencies are critical to the success of relief efforts and reduction in mortality. Measles has been one of the major causes of child deaths in humanitarian emergencies and further contributes to mortality by exacerbating malnutrition and vitamin A deficiency. Here, we review measles vaccination activities in humanitarian emergencies as documented in published literature. Our main interest was to review the available evidence focusing on the target age range for mass vaccination campaigns either in response to a humanitarian emergency or in response to an outbreak of measles in a humanitarian context to determine whether the current guidance required revision based on recent experience. METHODS: We searched the published literature for articles published from January 1, 1998 to January 1, 2010 reporting on measles in emergencies. As definitions and concepts of emergencies vary and have changed over time, we chose to consider any context where an application for either a Consolidated Appeals Process or a Flash Appeal to the UN Central Emergency Revolving Fund (CERF) occurred during the period examined. We included publications from countries irrespective of their progress in measles control as humanitarian emergencies may occur in any of these contexts and as such, guidance applies irrespective of measles control goals. RESULTS: Of the few well-documented epidemic descriptions in humanitarian emergencies, the age range of cases is not limited to under 5 year olds. Combining all data, both from preventive and outbreak response interventions, about 59% of cases in reports with sufficient data reviewed here remain in children under 5, 18% in 5-15 and 2% above 15 years. In instances where interventions targeted a reduced age range, several reports concluded that the age range should have been extended to 15 years, given that a significant proportion of cases occurred beyond 5 years of age. CONCLUSIONS: Measles outbreaks continue to occur in humanitarian emergencies due to low levels of pre-existing population immunity. According to available published information, cases continue to occur in children over age 5. Preventing cases in older age groups may prevent younger children from becoming infected and reduce mortality in both younger and older age groups.
format Online
Article
Text
id pubmed-3195113
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31951132011-10-18 Measles vaccination in humanitarian emergencies: a review of recent practice Grais, Rebecca F Strebel, Peter Mala, Peter Watson, John Nandy, Robin Gayer, Michelle Confl Health Research BACKGROUND: The health needs of children and adolescents in humanitarian emergencies are critical to the success of relief efforts and reduction in mortality. Measles has been one of the major causes of child deaths in humanitarian emergencies and further contributes to mortality by exacerbating malnutrition and vitamin A deficiency. Here, we review measles vaccination activities in humanitarian emergencies as documented in published literature. Our main interest was to review the available evidence focusing on the target age range for mass vaccination campaigns either in response to a humanitarian emergency or in response to an outbreak of measles in a humanitarian context to determine whether the current guidance required revision based on recent experience. METHODS: We searched the published literature for articles published from January 1, 1998 to January 1, 2010 reporting on measles in emergencies. As definitions and concepts of emergencies vary and have changed over time, we chose to consider any context where an application for either a Consolidated Appeals Process or a Flash Appeal to the UN Central Emergency Revolving Fund (CERF) occurred during the period examined. We included publications from countries irrespective of their progress in measles control as humanitarian emergencies may occur in any of these contexts and as such, guidance applies irrespective of measles control goals. RESULTS: Of the few well-documented epidemic descriptions in humanitarian emergencies, the age range of cases is not limited to under 5 year olds. Combining all data, both from preventive and outbreak response interventions, about 59% of cases in reports with sufficient data reviewed here remain in children under 5, 18% in 5-15 and 2% above 15 years. In instances where interventions targeted a reduced age range, several reports concluded that the age range should have been extended to 15 years, given that a significant proportion of cases occurred beyond 5 years of age. CONCLUSIONS: Measles outbreaks continue to occur in humanitarian emergencies due to low levels of pre-existing population immunity. According to available published information, cases continue to occur in children over age 5. Preventing cases in older age groups may prevent younger children from becoming infected and reduce mortality in both younger and older age groups. BioMed Central 2011-09-26 /pmc/articles/PMC3195113/ /pubmed/21942984 http://dx.doi.org/10.1186/1752-1505-5-21 Text en Copyright ©2011 Grais et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Grais, Rebecca F
Strebel, Peter
Mala, Peter
Watson, John
Nandy, Robin
Gayer, Michelle
Measles vaccination in humanitarian emergencies: a review of recent practice
title Measles vaccination in humanitarian emergencies: a review of recent practice
title_full Measles vaccination in humanitarian emergencies: a review of recent practice
title_fullStr Measles vaccination in humanitarian emergencies: a review of recent practice
title_full_unstemmed Measles vaccination in humanitarian emergencies: a review of recent practice
title_short Measles vaccination in humanitarian emergencies: a review of recent practice
title_sort measles vaccination in humanitarian emergencies: a review of recent practice
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195113/
https://www.ncbi.nlm.nih.gov/pubmed/21942984
http://dx.doi.org/10.1186/1752-1505-5-21
work_keys_str_mv AT graisrebeccaf measlesvaccinationinhumanitarianemergenciesareviewofrecentpractice
AT strebelpeter measlesvaccinationinhumanitarianemergenciesareviewofrecentpractice
AT malapeter measlesvaccinationinhumanitarianemergenciesareviewofrecentpractice
AT watsonjohn measlesvaccinationinhumanitarianemergenciesareviewofrecentpractice
AT nandyrobin measlesvaccinationinhumanitarianemergenciesareviewofrecentpractice
AT gayermichelle measlesvaccinationinhumanitarianemergenciesareviewofrecentpractice